Abbisko Cayman Limited (HKG:2256)
Hong Kong
· Delayed Price · Currency is HKD 9.95
-0.89 (-8.21%)
Jun 17, 2025, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 6.78 billion as of June 17, 2025. Its market cap has increased by 203.49% in one year.
Market Cap
6.78B
Enterprise Value
4.67B
Revenue
536.33M
Ranking
n/a
PE Ratio
254.66
Stock Price
9.95
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 6.78B, a decrease of -22.13%. That is a compound annual growth rate of -6.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 6.78B | 135.84% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 269.70B |
| Hansoh Pharmaceutical Group Company | 174.81B |
| Innovent Biologics | 133.28B |
| JD Health International | 130.24B |
| WuXi Biologics | 113.92B |
| CSPC Pharmaceutical Group | 101.03B |
| Sino Biopharmaceutical | 98.90B |
| Akeso | 86.03B |